Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_assertion description "[Selumetinib is an inhibitor of MEK1/MEK2, downstream of KRAS, with preclinical evidence of synergistic activity with docetaxel in KRAS-mutant cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_assertion evidence source_evidence_literature NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_assertion SIO_000772 23200175 NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_assertion wasDerivedFrom befree-20140225 NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_assertion wasGeneratedBy ECO_0000203 NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP632830.RA0RczjPjtF5u4HPDWVVTvNeq8sRZ2tOeR9o14nPZGAAU130_provenance.